Gilead Sciences

Gilead Sciences, founded in 1987, is an American biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for critical diseases. The company's core mission is to advance the care of patients suffering from life-threatening illnesses such as HIV, cancer, and inflammatory conditions. Gilead's product portfolio includes antiviral drugs, oncology treatments, and anti-inflammatory medications, with a strong focus on scientific innovation and health equity.

Notable figures associated with Gilead Sciences include its founder Michael L. Riordan and key investors such as BlackRock and Vanguard Group. The company has achieved significant milestones, including the development of groundbreaking antiviral therapies like Remdesivir for COVID-19 treatment. Gilead's impact is profound, having transformed the landscape of antiviral treatment and improved access to essential medicines globally.